A detailed history of First Horizon Advisors, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 2,472 shares of EXAS stock, worth $150,075. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,472
Previous 2,427 1.85%
Holding current value
$150,075
Previous $102,000 64.71%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$42.43 - $70.83 $1,909 - $3,187
45 Added 1.85%
2,472 $168,000
Q2 2024

Jul 19, 2024

SELL
$41.33 - $74.26 $7,067 - $12,698
-171 Reduced 6.58%
2,427 $102,000
Q1 2024

Apr 26, 2024

SELL
$56.27 - $73.77 $4,839 - $6,344
-86 Reduced 3.2%
2,598 $179,000
Q4 2023

Feb 06, 2024

BUY
$59.06 - $75.72 $3,248 - $4,164
55 Added 2.09%
2,684 $198,000
Q3 2023

Oct 27, 2023

SELL
$65.94 - $99.04 $27,496 - $41,299
-417 Reduced 13.69%
2,629 $179,000
Q2 2023

Aug 03, 2023

SELL
$62.68 - $95.05 $92,829 - $140,769
-1,481 Reduced 32.71%
3,046 $286,000
Q1 2023

May 15, 2023

SELL
$47.19 - $70.77 $73,569 - $110,330
-1,559 Reduced 25.62%
4,527 $306,000
Q4 2022

Feb 10, 2023

BUY
$30.35 - $53.15 $13,536 - $23,704
446 Added 7.91%
6,086 $301,000
Q3 2022

Nov 09, 2022

BUY
$31.97 - $49.37 $13,203 - $20,389
413 Added 7.9%
5,640 $182,000
Q2 2022

Aug 02, 2022

BUY
$35.61 - $76.23 $170,287 - $364,531
4,782 Added 1074.61%
5,227 $205,000
Q1 2022

May 10, 2022

SELL
$57.56 - $82.54 $119,782 - $171,765
-2,081 Reduced 82.38%
445 $31,000
Q4 2021

Feb 09, 2022

BUY
$72.5 - $100.68 $17,327 - $24,062
239 Added 10.45%
2,526 $196,000
Q3 2021

Nov 15, 2021

SELL
$90.24 - $124.05 $680,138 - $934,964
-7,537 Reduced 76.72%
2,287 $218,000
Q3 2021

Nov 09, 2021

BUY
$90.24 - $124.05 $700,262 - $962,628
7,760 Added 375.97%
9,824 $937,000
Q2 2021

Aug 09, 2021

BUY
$93.66 - $139.27 $91,318 - $135,788
975 Added 89.53%
2,064 $256,000
Q1 2021

May 11, 2021

BUY
$116.57 - $155.01 $80,316 - $106,801
689 Added 172.25%
1,089 $143,000
Q2 2020

Jul 31, 2020

BUY
$55.75 - $92.75 $12,934 - $21,518
232 Added 138.1%
400 $34,000
Q1 2020

May 05, 2020

SELL
$37.9 - $104.44 $2,653 - $7,310
-70 Reduced 29.41%
168 $9,000
Q4 2019

Jan 07, 2020

BUY
$77.66 - $99.74 $5,436 - $6,981
70 Added 41.67%
238 $22,000
Q3 2019

Oct 23, 2019

SELL
$90.37 - $122.49 $6,325 - $8,574
-70 Reduced 29.41%
168 $15,000
Q1 2019

Apr 26, 2019

BUY
$61.98 - $96.5 $14,751 - $22,967
238 New
238 $0

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.7B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.